Switching From Semaglutide to Tirzepatide: A Prescriber-Led Change

    Short answer

    There is no dose conversion between semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound), and neither tirzepatide label explains how to move over from semaglutide. Your prescriber decides which brand, which step you start on and when. Your part is the record: doses, side effects, meals and weight through the change.

    Moving from a semaglutide brand such as Ozempic, Wegovy or Rybelsus to a tirzepatide brand such as Mounjaro or Zepbound is a new prescribing decision. Your prescriber decides which brand, where you start and how quickly you step up. This guide covers what the Mounjaro (revised 08/2026) and Zepbound (revised 08/2026) labels say, what changes day to day, what to track and what to ask. It does not give doses, conversions or timing, because those decisions belong with your prescriber.

    The Short Answer

    No Milligram-for-Milligram Conversion

    Semaglutide and tirzepatide are different molecules, so a dose of one does not translate into a dose of the other. No official chart exists, and your prescriber chooses your tirzepatide dose.

    The Labels Do Not Cover Brand Switches

    The Mounjaro and Zepbound labels describe how new users begin and step up. Neither explains how to move over from a semaglutide brand, which is why the plan comes from your prescriber.

    Never Both at Once

    The Zepbound and Wegovy labels (the same ingredients as Mounjaro and Ozempic) both say combining the medicine with any other GLP-1 receptor agonist is not recommended. Your prescriber will tell you how to stop one and start the other.

    Your Record Matters Most Now

    Logging doses, side effects, meals and weight through the change shows how the new medicine is going. It also gives your prescriber facts instead of guesses at the next visit.

    Start by Naming Your Exact Brands

    Each brand has its own FDA label. Know exactly which one you are leaving and which you are joining.

    BrandIngredientFormApproved for
    OzempicSemaglutideWeekly injection or daily tabletType 2 diabetes; heart and kidney risk reduction in some adults
    RybelsusSemaglutideDaily tabletType 2 diabetes; heart event risk reduction in high-risk adults
    WegovySemaglutideWeekly injection or daily tabletWeight reduction, heart risk reduction, MASH (injection)
    MounjaroTirzepatideWeekly injection (pen or vial)Type 2 diabetes (adults and children 10+); heart event risk reduction in high-risk adults
    ZepboundTirzepatideWeekly injection (pen or vial)Weight reduction; obstructive sleep apnea in adults with obesity

    The Semaglutide Brand You Are Leaving

    Ozempic comes as a weekly injection or a daily tablet for type 2 diabetes, and Rybelsus is a daily tablet for type 2 diabetes. Wegovy comes as a weekly injection or a daily tablet with a label that includes weight reduction.

    The Tirzepatide Brand You Are Joining

    Mounjaro is approved for type 2 diabetes, including blood sugar control in adults and children 10 and older. Zepbound is approved for long-term weight reduction and for obstructive sleep apnea in adults with obesity.

    Why the Brand Matters

    Each brand has its own label, approved uses, forms and dose steps. Which tirzepatide brand fits depends on your diagnosis and your prescriber's judgment.

    Write Down Your Last Semaglutide Details

    Note the brand, form and the dose you were last prescribed before the switch. Your prescriber may ask, and having it written down saves guesswork.

    What the Tirzepatide Labels Say About Their First Step

    Each label lists a first step for people beginning that medicine for the first time. These are quoted as each label's own schedule for new users. They are not a switching plan and not a dose for you.

    The Mounjaro Label

    For people starting Mounjaro, the label's schedule lists 2.5 mg once weekly as the first step. It increases in 2.5 mg stages after at least 4 weeks on each dose, up to 15 mg for adults.

    The Zepbound Label

    For people starting Zepbound, the label's schedule also lists 2.5 mg once weekly as the first step, rising in 2.5 mg stages. Its maintenance doses for weight reduction are 5 mg, 10 mg or 15 mg.

    What the Labels Leave to Your Prescriber

    Neither label says where someone coming from semaglutide should begin. Your prescriber decides, using your history and how you have been doing on semaglutide.

    Why the Milligram Numbers Can't Be Compared

    Milligram amounts of different molecules can't be compared, so the numbers alone tell you nothing about strength.

    What Changes Day to Day

    Beyond the ingredient, a switch can change the routine itself.

    Two Receptors Instead of One

    Semaglutide acts on the GLP-1 receptor, while tirzepatide acts on both the GIP and GLP-1 receptors. That is the main pharmacological difference between the two.

    From a Daily Tablet to a Weekly Shot

    If you take Rybelsus, Ozempic tablets or Wegovy tablets, tirzepatide means a weekly injection instead, since there is no tirzepatide tablet. Your prescriber or pharmacist can show you how to use the pen or vial you are given.

    Shot Day, Logged in a Couple of Taps

    Pep AI logs each Mounjaro or Zepbound shot in a couple of taps with the schedule your prescriber set. The body map shows where your recent shots went, so rotating sites becomes routine. See the Mounjaro tracker and the Zepbound tracker.

    Shot-Day Reminders on Your Lock Screen

    Pep AI sends a shot-day reminder that shows on your Lock Screen, and your earlier semaglutide history stays in the log next to the new medicine. On iPhone, home-screen widgets, a Lock Screen Live Activity and an Apple Watch app show what is due at a glance.

    A Note for Birth Control Pill Users

    The Mounjaro and Zepbound labels include a note for people who use birth control pills. Ask your prescriber what it means for you before your first tirzepatide dose.

    What to Track Through the Change

    You cannot control the plan, but you can control the record.

    Doses as Prescribed

    Log your final semaglutide dose and every tirzepatide dose as you take it. When your prescriber asks how it went, the dates and steps are already in one place.

    Symptoms, When They Start and How Strong

    Pep AI's side-effect log has a built-in list of GLP-1 symptoms, plus your own, each rated for severity on the day you log it. Comparing those days with your dose dates makes a symptom far easier to describe.

    Meals, Protein and Water

    Appetite can change during a switch, and Pep AI keeps protein, fiber and water goals front and center. Log meals by photo scan, barcode, restaurant menu scan or search so they sit in the same app as your doses. More in the GLP-1 food tracker.

    Weight Across Both Medicines

    Pep AI keeps one weight trend and your progress photos across the old and new medicine. Weight can sync from Apple Health on iPhone or Health Connect on Android, so the trend keeps going on its own.

    Side Effects to Watch on Tirzepatide

    From each tirzepatide label's placebo-controlled trials, each read against its own placebo.

    Side effectZepbound (weight trials)Mounjaro (type 2 diabetes trials)
    Nausea25-29% vs 8% placebo12-18% vs 4% placebo
    Diarrhea19-23% vs 8% placebo12-17% vs 9% placebo
    Vomiting8-13% vs 2% placebo5-9% vs 2% placebo

    Common Effects on the Tirzepatide Labels

    Nausea, diarrhea, vomiting and constipation are the most common side effects on both tirzepatide labels. In Zepbound weight-reduction trials, nausea affected 25% to 29% of people compared with 8% on placebo.

    Your Semaglutide Weeks Are Not a Forecast

    Many effects overlap with semaglutide, but nobody can predict how you will feel on a new medicine. Log what happens rather than assuming it will match your past weeks.

    Signs That Need Medical Attention

    Severe stomach pain that will not go away, signs of an allergic reaction, or vomiting and diarrhea that cause dehydration need prompt care.

    The Boxed Warning on Tirzepatide

    The Mounjaro and Zepbound labels carry a boxed warning because tirzepatide caused thyroid C-cell tumors in rodents, and it is unknown whether this happens in people. Neither should be used by anyone with a personal or family history of medullary thyroid carcinoma (MTC) or with multiple endocrine neoplasia syndrome type 2 (MEN 2). Report a lump or swelling in the neck, trouble swallowing, hoarseness or shortness of breath.

    Full Guides on Side Effects

    The GLP-1 side effects guide covers the full label tables and warning signs, and the side effects tracker shows how logging them works.

    Questions to Ask Your Prescriber

    A switch goes better when you know what to ask.

    About the Plan

    Ask which tirzepatide brand you will use, which step you will start on and when to take your first dose. Ask how and when your dose will change after that.

    About Side Effects

    Ask which symptoms to expect, which ones mean you should call, and what to do if a step feels hard. Ask how they would like updates between visits.

    About Your Other Medicines

    Mention every medicine you take, since low blood sugar is more likely with insulin or a sulfonylurea. Tirzepatide also slows stomach emptying, which can change how some pills are absorbed.

    Bring Your Dose and Weight Record

    Pep AI turns your doses, injection sites, weight and daily meal totals into a PDF report you can share with your prescriber. Your prescriber sees doses of both medicines on one record instead of a reconstruction from memory.

    Key takeaways

    • There is no dose conversion between semaglutide and tirzepatide, and the tirzepatide labels do not cover switching from semaglutide.
    • Your prescriber decides which tirzepatide brand, which step you start on and when.
    • Milligram amounts of different molecules can't be compared, so the numbers alone tell you nothing about strength.
    • Semaglutide and tirzepatide are not taken together, and both carry the thyroid C-cell tumor boxed warning.
    • Log every dose, symptom, meal and weight through the change, and bring the PDF report of your doses and weight to your next visit.

    Whatever your prescriber decides, keep the record.

    Doses, side effects, meals and weight for any GLP-1 brand, in one app. Pep AI is free to try on iPhone and Android: a free download with a 3-day free trial, then a subscription.

    Download on the App StoreGet it on Google Play

    Frequently asked questions

    Keep reading

    Sources

    1. Mounjaro (tirzepatide) prescribing information, Eli Lilly / FDA (revised 08/2026)
    2. Zepbound (tirzepatide) prescribing information and Medication Guide, Eli Lilly / FDA (revised 08/2026)
    3. Ozempic (semaglutide) injection prescribing information, Novo Nordisk / FDA (revised 05/2026)
    4. Rybelsus and Ozempic (semaglutide) tablets prescribing information, Novo Nordisk / FDA (revised 01/2026)
    5. Wegovy (semaglutide) prescribing information and Medication Guide, Novo Nordisk / FDA (revised 06/2026)

    This guide is general information based on FDA prescribing information. It is not medical advice and does not give doses, conversions or timing. Only your prescriber can plan a switch, including when to stop one medicine, when to start the other and which step you start on. Dose steps quoted here are each label's own schedule for new users, not a switching plan. Pep AI is not affiliated with Novo Nordisk or Eli Lilly, and brand names are trademarks of their owners. If a symptom is severe or worrying you, contact your healthcare provider. In an emergency, call 911.

    Published by the Pep AI team · Updated November 2026